PT3046537T - Preparação farmacêutica de hidratos de carbono para utilização terapêutica - Google Patents

Preparação farmacêutica de hidratos de carbono para utilização terapêutica

Info

Publication number: PT3046537T
Authority: PT; Portugal
Prior art keywords: carbohydrates; pharmaceutical preparation; therapeutic use; therapeutic; pharmaceutical
Prior art date: 2013-09-16

Application number

PT14851464T

Other languages

English (en)

Original Assignee

Glycomine Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-16

Filing date

2014-09-16

Publication date

2021-10-07

2014-09-16 Application filed by Glycomine Inc filed Critical Glycomine Inc

2021-10-07 Publication of PT3046537T publication Critical patent/PT3046537T/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

PT14851464T 2013-09-16 2014-09-16 Preparação farmacêutica de hidratos de carbono para utilização terapêutica PT3046537T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201361878591P	2013-09-16	2013-09-16

Publications (1)

Publication Number	Publication Date
PT3046537T true PT3046537T (pt)	2021-10-07

Family

ID=52813726

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT211851522T PT3954360T (pt)	2013-09-16	2014-09-16	Preparação farmacêutica de hidratos de carbono para utilização terapêutica
PT14851464T PT3046537T (pt)	2013-09-16	2014-09-16	Preparação farmacêutica de hidratos de carbono para utilização terapêutica

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT211851522T PT3954360T (pt)	2013-09-16	2014-09-16	Preparação farmacêutica de hidratos de carbono para utilização terapêutica

Country Status (15)

Country	Link
US (6)	US20160228364A1 (pt)
EP (3)	EP3046537B1 (pt)
CY (1)	CY1125361T1 (pt)
DK (2)	DK3954360T3 (pt)
ES (2)	ES2892314T3 (pt)
FI (1)	FI3954360T3 (pt)
HR (2)	HRP20211564T1 (pt)
HU (2)	HUE071419T2 (pt)
LT (2)	LT3046537T (pt)
PL (2)	PL3046537T3 (pt)
PT (2)	PT3954360T (pt)
RS (2)	RS66755B1 (pt)
SI (2)	SI3046537T1 (pt)
SM (2)	SMT202100570T1 (pt)
WO (1)	WO2015053910A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2020252005B2 (en) *	2019-03-29	2025-11-27	Glycomine Inc.	Liposomal formulations, and methods of using and preparing thereof
US11058637B1 (en) *	2020-11-25	2021-07-13	King Abdulaziz University	Surface-modified emulsomes for intranasal delivery of drugs
JP2025517308A (ja) *	2022-05-18	2025-06-05	グライコミン，インコーポレイテッド	マンノース－１－ホスフェート、マンノース－１－ホスフェートの多形および組成物を生成するための連続フロー方法、ならびにそれらに関する使用
TW202600145A (zh) *	2024-02-29	2026-01-01	美商葛里柯麥公司	治療患有先天性醣基化障礙（ｃｄｇ）的個體的先天性醣基化障礙和共濟失調的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5013556A (en) *	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
US7189705B2 (en) *	2000-04-20	2007-03-13	The University Of British Columbia	Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7011845B2 (en) *	2000-05-09	2006-03-14	Mcp Hahnemann University	β-glucans encapsulated in liposomes
US7914714B2 (en) *	2003-05-14	2011-03-29	The Regents Of The University Of Colorado	Methods and apparatus using electrostatic atomization to form liquid vesicles
FR2897779B1 (fr) *	2006-02-24	2009-04-17	Orphan Europ Sarl	Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la
KR20100127842A (ko)	2008-03-26	2010-12-06	유니버시티 오브 옥스퍼드	소포체 표적화 리포좀
WO2010138550A1 (en) *	2009-05-27	2010-12-02	Northeastern University	Conjugated nanodelivery vehicles
CA3009891C (en)	2009-12-23	2020-09-15	Novartis Ag	Lipids, lipid compositions, and methods of using them
US20110257233A1 (en)	2010-03-19	2011-10-20	Sanford-Burnham Medical Research Institute	Benzoisothiazolones as inhibitors of phosphomannose isomerase
US9522183B2 (en) *	2010-07-31	2016-12-20	The Scripps Research Institute	Compositions and methods for inducing immune tolerance

2014
- 2014-09-16 DK DK21185152.2T patent/DK3954360T3/da active
- 2014-09-16 SM SM20210570T patent/SMT202100570T1/it unknown
- 2014-09-16 WO PCT/US2014/055921 patent/WO2015053910A2/en not_active Ceased
- 2014-09-16 HU HUE21185152A patent/HUE071419T2/hu unknown
- 2014-09-16 PL PL14851464T patent/PL3046537T3/pl unknown
- 2014-09-16 FI FIEP21185152.2T patent/FI3954360T3/fi active
- 2014-09-16 RS RS20250391A patent/RS66755B1/sr unknown
- 2014-09-16 LT LTEPPCT/US2014/055921T patent/LT3046537T/lt unknown
- 2014-09-16 HR HRP20211564TT patent/HRP20211564T1/hr unknown
- 2014-09-16 PL PL21185152.2T patent/PL3954360T3/pl unknown
- 2014-09-16 HR HRP20250522TT patent/HRP20250522T1/hr unknown
- 2014-09-16 EP EP14851464.9A patent/EP3046537B1/en active Active
- 2014-09-16 SM SM20250160T patent/SMT202500160T1/it unknown
- 2014-09-16 SI SI201431883T patent/SI3046537T1/sl unknown
- 2014-09-16 US US15/022,194 patent/US20160228364A1/en not_active Abandoned
- 2014-09-16 EP EP21185152.2A patent/EP3954360B1/en active Active
- 2014-09-16 SI SI201432105T patent/SI3954360T1/sl unknown
- 2014-09-16 RS RS20211212A patent/RS62641B1/sr unknown
- 2014-09-16 DK DK14851464.9T patent/DK3046537T3/da active
- 2014-09-16 PT PT211851522T patent/PT3954360T/pt unknown
- 2014-09-16 ES ES14851464T patent/ES2892314T3/es active Active
- 2014-09-16 PT PT14851464T patent/PT3046537T/pt unknown
- 2014-09-16 HU HUE14851464A patent/HUE056624T2/hu unknown
- 2014-09-16 EP EP25157136.0A patent/EP4563152A3/en active Pending
- 2014-09-16 ES ES21185152T patent/ES3026657T3/es active Active
- 2014-09-16 LT LTEP21185152.2T patent/LT3954360T/lt unknown
2017
- 2017-10-19 US US15/788,591 patent/US10449149B2/en active Active
2019
- 2019-09-11 US US16/568,098 patent/US11045419B2/en active Active
2021
- 2021-05-21 US US17/327,241 patent/US20220110871A1/en not_active Abandoned
- 2021-10-05 CY CY20211100863T patent/CY1125361T1/el unknown
2023
- 2023-03-30 US US18/193,328 patent/US20240082155A1/en not_active Abandoned
2024
- 2024-07-18 US US18/777,142 patent/US20250186345A1/en active Pending

Also Published As

Publication number	Publication date
ES2892314T3 (es)	2022-02-03
DK3954360T3 (da)	2025-05-12
RS62641B1 (sr)	2021-12-31
US20160228364A1 (en)	2016-08-11
LT3954360T (lt)	2025-05-12
HRP20250522T1 (hr)	2025-06-20
CY1125361T1 (el)	2023-03-24
SI3954360T1 (sl)	2025-06-30
PT3954360T (pt)	2025-04-30
US20250186345A1 (en)	2025-06-12
EP3954360B1 (en)	2025-02-12
PL3954360T3 (pl)	2025-07-07
EP4563152A3 (en)	2025-11-19
HUE056624T2 (hu)	2022-02-28
RS66755B1 (sr)	2025-05-30
HRP20211564T1 (hr)	2022-01-21
PL3046537T3 (pl)	2022-01-31
WO2015053910A3 (en)	2015-06-18
ES3026657T3 (en)	2025-06-11
SMT202500160T1 (it)	2025-05-12
EP4563152A2 (en)	2025-06-04
EP3954360A2 (en)	2022-02-16
HUE071419T2 (hu)	2025-08-28
US20180036239A1 (en)	2018-02-08
SMT202100570T1 (it)	2022-01-10
US11045419B2 (en)	2021-06-29
DK3046537T3 (da)	2021-10-11
SI3046537T1 (sl)	2022-01-31
FI3954360T3 (fi)	2025-05-15
US20200246266A1 (en)	2020-08-06
EP3046537A2 (en)	2016-07-27
LT3046537T (lt)	2021-12-10
US20240082155A1 (en)	2024-03-14
EP3954360A3 (en)	2022-06-01
US20220110871A1 (en)	2022-04-14
EP3046537B1 (en)	2021-07-14
EP3046537A4 (en)	2017-04-19
US10449149B2 (en)	2019-10-22
WO2015053910A2 (en)	2015-04-16

Publication	Publication Date	Title
IL287516A (en)	2021-12-01	Medicinal uses of empagliflozin
IL241101A0 (en)	2015-11-30	Medicinal uses of empagliflozin
IL244259A0 (en)	2016-04-21	Insertion of medical devices
IL241102A0 (en)	2015-11-30	Medicinal uses of empagliflozin
LT2981271T (lt)	2019-01-10	Empagliflozino terapinis panaudojimas
HUE067381T2 (hu)	2024-10-28	L-4-klórkinurenin dózisformái és terápiás alkalmazásai
IL245705B (en)	2021-05-31	Pharmaceutical dosage forms
ZA201600027B (en)	2018-07-25	Pharmaceutical preparation
SI3046537T1 (sl)	2022-01-31	Farmacevtski pripravek ogljikovih hidratov za terapevtsko uporabo
EP3052475A4 (en)	2017-05-03	Pharmaceutical use of 3-benzylsulfonylpropionitrile
ZA201506465B (en)	2021-06-30	Pharmaceutical preparation
GB201319595D0 (en)	2013-12-18	Combination of Analgesic drugs
GB201316468D0 (en)	2013-10-30	Combination of analgesic drugs
GB201318230D0 (en)	2013-11-27	Solutions for administration of pharmaceuticals